Technology

Hey! I am first heading line feel free to change me

Proteorex Therapeutics is developing small molecule drugs for challenging targets implicated in diseases with the highest unmet need. Many of these targets are well established and validated, but existing drug discovery technologies have failed to deliver viable treatments.

Hey! I am first heading line feel free to change me

The core of our method is an award-winning proprietary platform technology that enables the identification of novel small molecule lead compounds. Our approach allows us to address – and solve – problems that have plagued the drug discovery community for decades. The resulting drugs are tailored to the target, can be orally administered, and have the potential to replace expensive, often IV-administered biologics.

Hey! I am first heading line feel free to change me

Beyond the foundation, we incorporate cutting edge computational design and screening techniques as well as evaluating our molecules against patient-derived cell lines, the gold standard for therapeutic development. Our integrated approach towards drug discovery makes the process efficient and productive.

Proteorex is “expanding horizons to find cures”, using our award-winning, next generation proprietary drug design and discovery technology combined with high-powered computing and cutting-edge analytical tools to create a powerful drug discovery engine.